4-AcO-DALT

4-Acetyloxy-N,N-diallyltryptamine (or 4-AcO-DALT) is a tryptamine derivative. It has been sold as a designer drug, but little other information is available. It was first officially identified in seized drug samples in 2012.[1]

4-AcO-DALT
Names
Preferred IUPAC name
3-{2-[Di(prop-2-en-1-yl)amino]ethyl}-1H-indol-4-yl acetate
Other names
4-Acetyloxy-N,N-diallyltryptamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3
    Key: WRHFDIBXZYYCHO-UHFFFAOYSA-N
  • InChI=1/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3
    Key: WRHFDIBXZYYCHO-UHFFFAOYAV
  • CC(=O)Oc1cccc2c1c(c[nH]2)CCN(CC=C)CC=C
Properties
C18H22N2O2
Molar mass 298.386 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

References
  1. EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.